Cargando…
原发T790M突变非小细胞肺癌研究进展
With the development of sequencing technology, the detection rate of de novo T790M mutation is increasing. The emergence of the third generation of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) provide treatment opportunities. Secondary T790M mutation is often emphasized...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7665962/ https://www.ncbi.nlm.nih.gov/pubmed/31109443 http://dx.doi.org/10.3779/j.issn.1009-3419.2019.05.10 |